14 May , 2024
12:00 AM
14 May , 2024
12:00 AM
Results
View Details22 Feb , 2024
12:00 AM
02 Nov , 2023
12:00 AM
01 Sep , 2023
12:00 AM
01 Sep , 2023
12:00 AM
BookCloser
View DetailsNo Record Found
CALLS | PUTS | |||||||||
Total OI | Chg in Ol | Chg % Ol | LTP | Chg % | Strike Price | Chg % | LTP | Chg % OI | Chg in Ol | Total OI |
No Record Found
sector: Healthcare
as on 7/3/2024 10:59:42 AM
₹ 37.5 0.15 0.4014 May , 2024
12:00 AM
14 May , 2024
12:00 AM
Results
View Details22 Feb , 2024
12:00 AM
02 Nov , 2023
12:00 AM
01 Sep , 2023
12:00 AM
01 Sep , 2023
12:00 AM
BookCloser
View DetailsNo Record Found
No Record Found
Resolution Type | Desc. of Resolution | Lias Recommendation |
---|
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
Demat Account
Trading Account
PROMOTER - TOTAL57.04%
Indian: 57.04%
Foreign: 0%
NON-PROMOTER - TOTAL 42.96%
Institutions: 0.00%
Non-Institutions: 42.96%
CUSTODIES - 0.00%
Custodies: 0.00%
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Revenue | -- | -- | -- | -- |
yoy growth (%) | -- | -- | -- | -- |
Raw materials | -- | -- | -- | -- |
As % of sales | -- | -- | -- | -- |
Employee costs | -- | -- | -- | -- |
As % of sales | -- | -- | -- | -- |
Other costs | -- | -- | -- | -- |
As % of sales | -- | -- | -- | -- |
Operating profit | -- | -- | -- | -- |
OPM | -- | -- | -- | -- |
Depreciation | -- | -- | -- | -- |
Interest expense | -- | -- | -- | -- |
Other income | -- | -- | -- | -- |
Profit before tax | -- | -- | -- | -- |
Taxes | -- | -- | -- | -- |
Tax rate | -- | -- | -- | -- |
Minorities and other | -- | -- | -- | -- |
Adj. profit | -- | -- | -- | -- |
Exceptional items | -- | -- | -- | -- |
Net profit | -- | -- | -- | -- |
yoy growth (%) | -- | -- | -- | -- |
NPM | -- | -- | -- | -- |
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Equity capital | -- | -- | -- | -- |
Preference capital | -- | -- | -- | -- |
Reserves | -- | -- | -- | -- |
Net worth | -- | -- | -- | -- |
Minority interest | -- | -- | -- | -- |
Debt | -- | -- | -- | -- |
Deferred tax liabilities (net) | -- | -- | -- | -- |
Total liabilities | -- | -- | -- | -- |
Fixed assets | -- | -- | -- | -- |
Intangible assets | -- | -- | -- | -- |
Investments | -- | -- | -- | -- |
Deferred tax asset (net) | -- | -- | -- | -- |
Net working capital | -- | -- | -- | -- |
Inventories | -- | -- | -- | -- |
Inventory Days | -- | -- | -- | -- |
Sundry debtors | -- | -- | -- | -- |
Debtor days | -- | -- | -- | -- |
Other current assets | -- | -- | -- | -- |
Sundry creditors | -- | -- | -- | -- |
Creditor days | -- | -- | -- | -- |
Other current liabilities | -- | -- | -- | -- |
Cash | -- | -- | -- | -- |
Total assets | -- | -- | -- | -- |
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Profit before tax | -- | -- | -- | -- |
Depreciation | -- | -- | -- | -- |
Tax paid | -- | -- | -- | -- |
Working capital | -- | -- | -- | -- |
Other operating items | -- | -- | -- | -- |
Operating cashflow | -- | -- | -- | -- |
Capital expenditure | -- | -- | -- | -- |
Free cash flow | -- | -- | -- | -- |
Equity raised | -- | -- | -- | -- |
Investments | -- | -- | -- | -- |
Debt financing/disposal | -- | -- | -- | -- |
Dividends paid | -- | -- | -- | -- |
Other items | -- | -- | -- | -- |
Net in cash | -- | -- | -- | -- |
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Growth matrix (%) | -- | -- | -- | -- |
Revenue growth | -- | -- | -- | -- |
Op profit growth | -- | -- | -- | -- |
EBIT growth | -- | -- | -- | -- |
Net profit growth | -- | -- | -- | -- |
Profitability ratios (%) | -- | -- | -- | -- |
OPM | -- | -- | -- | -- |
EBIT margin | -- | -- | -- | -- |
Net profit margin | -- | -- | -- | -- |
RoCE | -- | -- | -- | -- |
RoNW | -- | -- | -- | -- |
RoA | -- | -- | -- | -- |
Per share ratios (₹) | -- | -- | -- | -- |
EPS | -- | -- | -- | -- |
Dividend per share | -- | -- | -- | -- |
Cash EPS | -- | -- | -- | -- |
Book value per share | -- | -- | -- | -- |
Valuation ratios | -- | -- | -- | -- |
P/E | -- | -- | -- | -- |
P/CEPS | -- | -- | -- | -- |
P/B | -- | -- | -- | -- |
EV/EBIDTA | -- | -- | -- | -- |
Payout (%) | -- | -- | -- | -- |
Dividend payout | -- | -- | -- | -- |
Tax payout | -- | -- | -- | -- |
Liquidity ratios | -- | -- | -- | -- |
Debtor days | -- | -- | -- | -- |
Inventory days | -- | -- | -- | -- |
Creditor days | -- | -- | -- | -- |
Leverage ratios | -- | -- | -- | -- |
Interest coverage | -- | -- | -- | -- |
Net debt / equity | -- | -- | -- | -- |
Net debt / op. profit | -- | -- | -- | -- |
Cost breakup (₹) | -- | -- | -- | -- |
Material costs | -- | -- | -- | -- |
Employee costs | -- | -- | -- | -- |
Other costs | -- | -- | -- | -- |
Particulars ( Rupees In Crores.) | -- | -- | -- | -- | -- |
---|---|---|---|---|---|
Gross Sales | -- | -- | -- | -- | |
Excise Duty | -- | -- | -- | -- | |
Net Sales | -- | -- | -- | -- | |
Other Operating Income | -- | -- | -- | -- | |
Other Income | -- | -- | -- | -- | |
Total Income | -- | -- | -- | -- | |
Total Expenditure ** | -- | -- | -- | -- | |
PBIDT | -- | -- | -- | -- | |
Interest | -- | -- | -- | -- | |
PBDT | -- | -- | -- | -- | |
Depreciation | -- | -- | -- | -- | |
Minority Interest Before NP | -- | -- | -- | -- | |
Tax | -- | -- | -- | -- | |
Deferred Tax | -- | -- | -- | -- | |
Reported Profit After Tax | -- | -- | -- | -- | |
Minority Interest After NP | -- | -- | -- | -- | |
Net Profit after Minority Interest | -- | -- | -- | -- | |
Extra-ordinary Items | -- | -- | -- | -- | |
Adjusted Profit After Extra-ordinary item | -- | -- | -- | -- | |
EPS (Unit Curr.) | -- | -- | -- | -- | |
Book Value (Unit Curr.) | -- | -- | -- | -- | |
Dividend (%) | -- | -- | -- | -- | |
Equity | -- | -- | -- | -- | |
Public Shareholding (Number) | -- | -- | -- | -- | |
Public Shareholding (%) | -- | -- | -- | -- | |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | |
Non Encumbered - No. of Shares | -- | -- | -- | -- | |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | |
PBIDTM(%) | -- | -- | -- | -- | |
PBDTM(%) | -- | -- | -- | -- | |
PATM(%) | -- | -- | -- | -- |
No Record Found
Particulars ( Rupees In Crores.) | -- | -- | -- | -- | -- |
---|---|---|---|---|---|
Gross Sales | -- | -- | -- | -- | |
Excise Duty | -- | -- | -- | -- | |
Net Sales | -- | -- | -- | -- | |
Other Operating Income | -- | -- | -- | -- | |
Other Income | -- | -- | -- | -- | |
Total Income | -- | -- | -- | -- | |
Total Expenditure ** | -- | -- | -- | -- | |
PBIDT | -- | -- | -- | -- | |
Interest | -- | -- | -- | -- | |
PBDT | -- | -- | -- | -- | |
Depreciation | -- | -- | -- | -- | |
Minority Interest Before NP | -- | -- | -- | -- | |
Tax | -- | -- | -- | -- | |
Deferred Tax | -- | -- | -- | -- | |
Reported Profit After Tax | -- | -- | -- | -- | |
Minority Interest After NP | -- | -- | -- | -- | |
Net Profit after Minority Interest | -- | -- | -- | -- | |
Extra-ordinary Items | -- | -- | -- | -- | |
Adjusted Profit After Extra-ordinary item | -- | -- | -- | -- | |
EPS (Unit Curr.) | -- | -- | -- | -- | |
Book Value (Unit Curr.) | -- | -- | -- | -- | |
Dividend (%) | -- | -- | -- | -- | |
Equity | -- | -- | -- | -- | |
Public Shareholding (Number) | -- | -- | -- | -- | |
Public Shareholding (%) | -- | -- | -- | -- | |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | |
Non Encumbered - No. of Shares | -- | -- | -- | -- | |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | |
PBIDTM(%) | -- | -- | -- | -- | |
PBDTM(%) | -- | -- | -- | -- | |
PATM(%) | -- | -- | -- | -- |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd | 915.25 | 129.02 | 88,657.85 | 241.77 | 0.16 | 610.11 | 79.03 |
Apollo Hospitals Enterprise Ltd | 6,159.75 | 86.80 | 87,717.27 | 238.80 | 0.10 | 1,894.60 | 536.28 |
Fortis Healthcare Ltd | 470.95 | 279.66 | 34,626.16 | 68.33 | 0.22 | 307.48 | 120.37 |
Global Health Ltd | 1,278.85 | 94.84 | 34,226.64 | 92.24 | 0.00 | 578.65 | 106.10 |
Narayana Hrudayalaya Ltd | 1,232.35 | 58.86 | 24,984.13 | 158.09 | 0.33 | 846.31 | 90.05 |
The Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, name of the Company changed from Abhi Diagnostic Imagings Private Limited to Nidan Laboratories And Healthcare Private Limited under the Companies Act, 2013 pursuant to a Special Resolution passed by Shareholders at the EGM held on February 26, 2021 and had obtained fresh Certificate of Incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, Company got converted into a Public Limited Company and name of the Company was changed to Nidan Laboratories And Healthcare Limited and a fresh Certificate of Incorporation consequent upon conversion to Public Limited Company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021. The Company carry on the business of Diagnostic Centre, such as X-Ray, Sonography, 2 D ECHO, PFT, CST, C.T. Scan, MRI etc., Blood Bank, Pathology Laboratories, Dialysis Unit, Intensive Care Unit, Burn & Poisoning Centre and Poly Clinic.Nidan was established as a Proprietary Firm in 1994 by Promoter, Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The Company came into existence in the year 2000. The business was carried out under the sole proprietorship, which... Read More
Reports by Nidan Laboratories & Healthcare Ltd
Reports by Nidan Laboratories & Healthcare Ltd
No Record Found
ATTENTION INVESTORS
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Risk Disclosure on Derivatives
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
We are ISO 27001:2013 Certified.
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.